about
Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagementHuman IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironmentSynchrotron microbeam irradiation induces neutrophil infiltration, thrombocyte attachment and selective vascular damage in vivoA differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms.Cell death in immune thrombocytopenia: novel insights and perspectives.IVIG regulates the survival of human but not mouse neutrophils.Glycomic analysis of human mast cells, eosinophils and basophils.Microbial glycan microarrays define key features of host-microbial interactions.Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment.Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular diseaseAntibody repertoire profiling with mimotope arrays.Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites.Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes.Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg).Basic and clinical immunology of SiglecsIntravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclassThe Potential Use of Pharmacological Agents to Modulate Orthodontic Tooth Movement (OTM).Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.Cell death modulation by intravenous immunoglobulin.Targeting siglecs--a novel pharmacological strategy for immuno- and glycotherapy.Update in clinical allergy and immunology.Mechanisms and potential therapeutic targets in allergic inflammation: recent insights.Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.Basophils exhibit antibacterial activity through extracellular trap formation.Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations.Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells.Siglec-7/-9 ligands shield tumor cells from NK cell attack.Innate lymphoid cells in asthma: cannabinoids on the balance.Different patterns of Siglec-9-mediated neutrophil death responses in septic shock.Isolation of Antibodies from Human Plasma, Saliva, Breast Milk, and Gastrointestinal Fluid.Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cellsIVIG pluripotency and the concept of Fc-sialylation: challenges to the scientistGranulocyte Death Regulation by Naturally Occurring AutoantibodiesDimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypesIntravenous immunoglobulin preparations contain anti–Siglec-8 autoantibodiesImmunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparationsSialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytesThe Interleukin-13 Production by Peripheral Blood T Cells from Atopic Dermatitis Patients Does Not Require CD2 Costimulation
P50
Q28258592-FB61E097-1304-495D-812A-A2551A6EFBA0Q28910424-1B689B03-1CF3-468E-BE50-82BCA67DAA3FQ30812791-83EB60ED-999C-4C14-9E05-6170D6531AF0Q31040502-37FB3559-ED0F-4FF2-BF19-E3DACCC93E1AQ33407615-D6667A9D-D6BF-4E8E-8629-16511F230ADBQ33683531-35B42E08-9A51-4696-B67A-ECCA3033B177Q33949464-522305E5-8941-4EAC-A9A1-67FE6D5240B5Q34154041-8DAF9EC5-23CC-4E73-A6B0-3A01DE33695BQ34411053-804111A5-8DB9-4E1C-9CD9-1EF3ABF46578Q36130814-551657C9-8988-420E-86C0-0DAF7E9A51B0Q36215753-D90F8D7F-3F95-4388-AA71-95DC628AFE5CQ36592223-7E4ED814-528A-46BE-95C0-C047A197A445Q36894391-9C5C9CE9-F1B0-423B-BC4B-AFE3411DFA37Q37170492-60EF9712-4F31-4228-8C12-CF37A0B0E8EFQ37192864-FBB6E438-9A89-40A2-994A-A0A8A0757B92Q37348437-62132C3C-984B-42BC-AA1D-6B455195DEC3Q37421977-4236ED3E-9AB6-4B59-9071-D5E11EAB8C71Q37629885-80FFD492-424B-4B61-A082-1429E7886A8DQ37679918-5E2D9091-AE45-41D4-B78E-99B5E14B8A08Q37734264-C3708BF2-CC2E-4BDE-9676-9F3B0411790EQ37887097-05B6A16E-D848-476E-BE51-5E2AC12BFFE7Q38056516-069A7E66-2D9E-4FB9-B0F1-078E39F2C455Q38161574-3C7502C0-FD4F-4540-86F2-BF1B66A3D800Q38285397-06BEAFA6-0C43-4C73-ABD9-6691FD8C0AF1Q38820288-199197EF-EDEC-4CB8-8A3F-D82240588E51Q41185213-F9ED745C-6856-49CD-9A6D-72F9EB7FBB1BQ44681531-607AA172-B055-4F23-A3D8-FD425A9CE0E8Q45646848-CE918157-9670-485F-B92A-05A52C53E129Q46573945-25A702A4-1379-4FE0-B055-ADE305BDD12AQ48207141-539B49C6-8F72-4217-AE98-FEBBE74EB479Q51762803-43833667-62BC-4410-8D21-FEAC9774D7C2Q53726982-FDD87245-6EE8-4705-BA7E-EB031FD19FC8Q56889933-98147549-4FAA-4B06-B568-B9B136AF22BCQ58861220-6A19D384-3DAA-4CED-9B6A-A8CB67C242ACQ61959724-18D4A74C-F38B-4F04-81D2-FDB360662768Q61959729-6D0E64D1-C5C2-4DBF-BA7B-F882D9BB8E42Q61959765-931DCAC9-EE3F-4277-8F76-443908810E03Q61959774-55FC3B88-5D57-4078-8BA4-F39A3238B4C7Q61959775-5684EAE9-E2CF-4B93-9861-6700C7483981Q61959799-42D6A58E-C43F-46F4-BA4B-A7EBC01822A1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stephan von Gunten
@ast
Stephan von Gunten
@en
Stephan von Gunten
@es
Stephan von Gunten
@nl
Stephan von Gunten
@sl
type
label
Stephan von Gunten
@ast
Stephan von Gunten
@en
Stephan von Gunten
@es
Stephan von Gunten
@nl
Stephan von Gunten
@sl
prefLabel
Stephan von Gunten
@ast
Stephan von Gunten
@en
Stephan von Gunten
@es
Stephan von Gunten
@nl
Stephan von Gunten
@sl
P106
P1153
6602594780
P21
P2798
P31
P496
0000-0002-2753-8738